Cisteo Medical has been acquired by Agôn Electronics, enhancing its capacity to innovate in the growing MedTech sector.

Information on the Target

Cisteo Medical, a leading French company specializing in active medical implants, has recently joined the Agôn Electronics industrial group. Founded in 2010 in the microtechnology hub of Besançon, Cisteo Medical has established itself as a key player in the design, manufacture, and approval of complex medical devices, including active implants. The company is renowned for its high-value products such as neurostimulators, pacemakers, medical electrodes, and reconstruction devices. As of November 13, 2024, Cisteo Medical has completed the sale of 100% of its shares to Agôn Electronics, with the transaction expected to finalize by the end of 2025.

This partnership establishes a vital step forward for Cisteo Medical, providing it with the necessary resources to enhance its industrial capabilities amid a highly competitive international market and increasing regulatory demands. With a workforce of 60 employees and a projected revenue of 5 million euros for 2025, the company is set to grow under the umbrella of a larger entity.

Industry Overview in France

The medical device sector remains one of the most promising areas within the global healthcare landscape. Currently valued at approximately $681.57 billion, the market for medical devices is projected to reach $955.49 bil

View Source

Similar Deals

Charles River Laboratories PathoQuest

2026

Merger Bio Diagnostics & Testing France
Ipsen ImCheck Therapeutics

2025

Merger Bio Therapeutic Drugs France
Zydus Lifesciences Limited Amplitude Surgical SA

2025

Merger Medical Prosthetics France
Sanofi Vicebio Ltd

2025

Merger Biotechnology & Medical Research (NEC) France
Biotrial ExactCure

2024

Merger Pharmaceuticals (NEC) France

Agôn Electronics

invested in

Cisteo Medical

in 2024

in a Merger deal

Disclosed details

Revenue: $5M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert